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Abstract
Introduction—We found isolated or clustered trophoblasts in the chorionic connective tissue of
the extraplacental membranes, and defined this novel histologic feature as the “trophoblast islands
of the chorionic connective tissue” (TICCT). This study was conducted to determine the clinical
significance of TICCT.
Methods—Immunohistochemistry for cytokeratin-7 was performed on the chorioamniotic
membranes (N=2155) obtained from singleton pregnancies of 1199 uncomplicated term and 956
preterm deliveries. The study groups comprised 1236 African-American and 919 Hispanic
women. Gestational age ranged from 24+0 weeks to 41+6 weeks. Multiple logistic regression
analysis was performed to investigate the magnitude of association between patient characteristics
and the presence of TICCT.
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Results—The likelihood of TICCT was significantly associated with advancing gestational age
both in term (OR: 1.29, 95% CI: 1.16–1.45, p<0.001) and preterm deliveries (OR: 1.19, 95% CI:
1.07–1.32, p=0.001). Hispanic women were less likely than African-American women to have
TICCT across gestation in term (OR: 0.23, 95% CI: 0.18–0.31, p<0.001) and preterm pregnancies
(OR: 0.41, 95% CI: 0.29–0.58, p<0.001). Women with a female fetus were significantly more
likely to have TICCT than women with a male fetus, in both term (OR: 1.64, 95% CI: 1.28–2.11,
p<0.001) and preterm gestations (OR: 2.04, 95% CI: 1.46–2.85, p<0.001). TICCT was 40% less
frequent in the presence of chronic placental inflammation [term (OR: 0.60, 95% CI: 0.45–0.81,
p=0.001) and preterm gestations (OR: 0.58, 95% CI: 0.40–0.84, p=0.003)] and in parous women at
term (OR: 0.60, 95% CI: 0.44–0.81, p=0.001).
Conclusions—Our findings suggest that the duration of pregnancy, fetal sex, and parity may
influence the behavior of extravillous trophoblast and placental mesenchymal cells.
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1. Introduction
The chorioamniotic membranes play an important role in the maintenance of pregnancy and
parturition [1–6]. The chorion laeve is composed of a trophoblast layer harboring stratified
extravillous trophoblasts and a connective tissue layer containing myofibroblasts and
macrophages [7–9]. Chorionic trophoblasts serve as a fetal immune barrier against maternal
immunocytes and predominantly express and produce non-classical, non-polymorphic HLA-
G, but do not express classical HLA class I and II molecules [10–12]. The trophoblasts of
the chorion laeve have also been implicated in the regulation of prostaglandin metabolism
and, therefore, in the regulation of myometrial contractility [13–16]. These cells express
high levels of 15-hydroxy-prostaglandin dehydrogenase, which can inactivate prostaglandins
by oxidation of these compounds to inactive 15-keto metabolites [17,18]. In addition to the
conventional roles, phagocytic activity in the chorionic trophoblasts has been reported when
chorioamnionitis is diagnosed, an observation that suggests another important role of the
trophoblast in the chorion laeve for the innate immune response [19].
Integrins and CD9 (surface molecules) have been implicated in the regulation of extravillous
trophoblast invasion [20,21]. Chorionic trophoblasts normally display a unidirectional
invasion toward the decidua where they intermingle with decidual cells of maternal origin
[22,23]. Therefore, the chorionic connective tissue, which is surrounded by the basal lamina
from the chorionic trophoblast layer, is not expected to contain any trophoblasts [2]. Yet, we
found some oval to polygonal cells in the chorionic connective tissue layer of the
chorioamniotic membranes. These cells had glassy, eosinophilic or amphophilic cytoplasm,
and were morphologically different from myofibroblasts or macrophages. Some of these
cells had cytological features indistinguishable from those of chorionic trophoblasts.
Subsequent immunostaining for cytokeratin-7 and HLA-G demonstrated co-localization of
strong immunoreactivity in these cells. Based on their characteristic morphological and
immunohistochemical features, we termed this novel histological finding of unknown
significance as the “trophoblast islands of the chorionic connective tissue” (TICCT).
The aim of this study was to determine the clinical significance of TICCT by analyzing the
chorioamniotic membranes obtained from women who presented with different obstetrical
conditions such as normal delivery at term, preterm delivery, and preeclampsia. We
conducted an immunohistochemical screening of a large number of cases across gestation
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for the detection of TICCT in two different study populations. The relationship between the
frequency of TICCT and various placental pathologies was also assessed.
2. Materials and methods
2.1. Tissue materials
To evaluate for TICCT, one chorioamniotic membrane roll section from each pregnant
woman was examined. Paraffin blocks of the membrane rolls were retrieved from the Bank
of Biological Materials of Wayne State University, which has been assembled in
collaboration with the Perinatology Research Branch of the Eunice Kennedy Shriver
National Institute of Child Health and Human Development, National Institutes of Health,
U.S. Department of Health and Human Services (NICHD/NIH/DHHS). The study groups
included 1236 African-American women who delivered at Hutzel Women’s Hospital,
Detroit, Michigan, USA, and 919 Hispanic women who delivered at the Sótero del Río
Hospital, Santiago, Chile. All women provided written informed consent, and the
Institutional Review Boards of the participating institutions approved the collection and use
of biological samples and clinical data for research purposes.
2.2. Immunofluorescence staining/immunohistochemistry
For double immunofluorescence staining, 5-µm-thick frozen tissue sections of the
chorioamniotic membranes were used. The frozen sections were ethanol-fixed for 5 min,
and used for immunofluorescence staining. A mouse monoclonal anti-HLA-G antibody
(MEM-G1, 1:50 dilution; Abcam, Cambridge, MA, USA) and a rabbit polyclonal anti-
cytokeratin 7 antibody (1:50 dilution; Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA) were used as primary antibodies. Alexa Fluor® 488 donkey anti-rabbit IgG and Alexa
Fluor® 594 donkey anti-mouse IgG were used as secondary antibodies (1:1000 dilution for
both; Invitrogen, Carlsbad, CA, USA), and the slides were mounted in ProLong Gold
antifade reagent with DAPI (Invitrogen). The immunofluorescence stained sections were
evaluated with a Leica TCS SP5 confocal microscope (Leica Microsystems, Wetzlar,
Germany).
For immunohistochemistry, formalin-fixed, paraffin-embedded, 5-µm-thick tissue sections
of the chorioamniotic membranes were obtained on silanized slides. Deparaffinization,
antigen retrieval, and immunostaining were done using a Ventana Discovery automatic
staining system (Ventana Medical Systems, Tucson, AZ, USA). A mouse monoclonal anti-
cytokeratin-7 antibody (OV-TL, 1:2000 dilution; Dako, Carpinteria, CA, USA) was a
primary antibody, and the Discovery® DAB Map™ Kit (Ventana Medical Systems) was
used for chromogen reaction.
2.3. Definition and grading of trophoblast islands of the chorionic connective tissue
(TICCT)
We defined TICCT as the presence of cytokeratin-7-positive cells or cell clusters with
cytological characteristics of trophoblasts in the chorionic connective tissue layer of the
reflected chorion (rather than the placental amnion). The extent of TICCT was graded as
follows: grade 1, when TICCT was observed in three or less isolated high-power fields
(HPFs, X400); grade 2, when TICCT was observed in four to 10 isolated HPFs; grade 3,
when TICCT was multifocal in more than 10 isolated HPFs; and grade 0, when none of
these were observed. All cases (n = 2155) were reviewed by one pathologist (CJK) who was
blinded to the clinical information while reviewing the immunostaining results. To
determine intra- and inter-observer reliability in the diagnosis of TICCT, 398 cases which
consisted of grade 0 (n=199), grade 1 (n=119), grade 2 (n=50), and grade 3 (n=30), selected
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by another author (JSH), were re-examined independently by two pathologists (CJK, JSK)
who were blinded to the original results.
2.4. Transmission electron microscopy
The chorioamniotic membranes in the paraffin blocks were deparaffinized using xylene and
rehydrated through serial incubations in graded ethanol. After rinsing with distilled water,
the samples were incubated with 0.1 mol/L phosphate buffer (pH 7.4). Deparaffinized
samples were stained with 1% OsO4 for 1 h and dehydrated with graded ethanol. Semi-thin
sections of epoxy resin–embedded tissues were evaluated to locate the areas with
trophoblasts in TICCT, and ultra-thin sections were examined using a JEM-1200EX II
transmission electron microscope (JEOL Ltd., Tokyo, Japan).
2.5. Placental pathology
To determine whether the frequency of TICCT was associated with specific pathological
changes of the placenta, we examined the relationship between this finding and the presence
or absence of four categories of placental lesions: 1) amniotic fluid infection (acute
chorioamnionitis); 2) maternal vascular underperfusion; 3) fetal vascular thrombo-occlusive
disease; and 4) chronic placental inflammation (villitis of unknown etiology/chronic
chorioamnionitis/chronic deciduitis). These samples were retrieved from the files
maintained at Wayne State University and the Detroit Medical Center in collaboration with
the Perinatology Research Branch, NICHD/NIH/DHHS.
2.6. Statistical analysis
Pearson’s chi-square test for categorical variables and the t-test for continuous variables
were performed to determine differences among maternal characteristics according to the
TICCT results. Pearson’s chi-square test and the linear by linear association were used to
assess the magnitude of association between TICCT and gestational age at delivery. The
association between TICCT and ethnicity across gestation was tested using the Mantel-
Haenszel (M-H) test. Multiple logistic regression analysis was performed to evaluate the
magnitude of association between selected patient characteristics and TICCT, adjusting for
potentially confounding factors selected based on clinical knowledge. The association
between high-grade TICCT (grade 2 or 3) and the related factors was tested by multinomial
regression. To determine intra- and inter-observer reliability in the diagnosis of TICCT,
quadratic weighted κ (κw) statistics [24] were calculated using R (A language and
environment for statistical computing. R Foundation for Statistical Computing, Vienna,
Austria. ISBN 3-900051-07-0, URL http://www.R-project.org). All statistical analyses
except κw were conducted using SPSS version 18.0 software (SPSS, Inc., Chicago, IL,
USA). A 5% threshold was used to determine statistical significance.
3. Results
3.1. Patterns of trophoblast islands of the chorionic connective tissue (TICCT)
To confirm the extravillous trophoblast phenotype of the cells, double immunofluorescence
staining was performed for cytokeratin-7 and HLA-G in frozen chorioamniotic membrane
tissues of four cases of African-American origin with prominent TICCT. These cells showed
variable degrees of HLA-G immunoreactivity along with strong cytoplasmic cytokeratin-7
immunofluorescent signals (Fig. 1a–d). Cytokeratin-7-positive TICCT was observed as an
isolated single cell or clusters of cells with variable sizes (Fig. 2a–h). Some TICCT clusters
featured a direct extension from the basal portion of the chorionic trophoblast layer with
interruption of the basal lamina, which was consistent with the features of migration of the
chorionic trophoblasts into the connective tissue layer (Fig. 2a–d). On the other hand, many
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TICCT clusters were noted as isolated trophoblasts in the middle of the chorionic connective
tissue without clear continuity with the chorionic trophoblast layer (Fig. 2e,f). Small cells
with little but clearly cytokeratin-positive cytoplasm were commonly detected at the
junction of the chorionic trophoblast and connective tissue layers (Fig. 2g,h).
To further determine whether TICCT clusters are largely derived from direct extensions
from the chorionic trophoblast layer, we performed immunohistochemical screening of 20
serial cytokeratin-7-immunostained sections from seven cases with TICCT. Serial sections
demonstrated the direct extension of some TICCT cells from the chorionic trophoblast layer,
but many of the TICCT cells did not show connections with the underlying chorionic
trophoblast layer in the serial sections (Fig. 3). We then examined the nature of TICCT cells
using electron microscopy in a case with TICCT. The TICCT cells had euchromatic nuclei
with prominent nucleoli, abundant intermediate filaments, a fair number of rough
endoplasmic reticula and mitochondria, and short microvilli on the cell surface (Fig. 4).
These ultrastructural features suggested a unique differentiation in the phenotype of these
trophoblastic cells in the TICCT.
3.2. TICCT in the chorioamniotic membranes of uncomplicated term pregnancies
The histologic diagnosis of TICCT was reproducible. The κw value for intra-observer
reliability in the diagnosis of TICCT was 0.807 (95% CI: 0.764–0.850), and the κw value for
inter-observer reliability was 0.816 (95% CI: 0.777–0.856), both of which are considered
excellent. TICCT was observed in 49.0% (587/1199) of placentas from uncomplicated
deliveries at term (African-American and Hispanic women). Specific regional distribution
patterns of TICCT in a given membrane roll were not observed. TICCT detection rates at
gestational weeks 37, 38, 39, 40, and 41 were 35.7%, 37.6%, 48.5%, 57.8%, and 65.4%,
respectively (Fig. 5). The rate of TICCT and gestational age at delivery were significantly
correlated (p<0.001 by linear-by-linear association). The rate of TICCT in the placentas of
African-American women was significantly higher than in those of Hispanic women from
37 weeks to 41 weeks of gestation (p<0.001 by M-H test) (Fig. 5).
The relationship between clinical parameters and TICCT in patients who delivered at term is
summarized in Table 1. The presence of TICCT was associated with significantly higher
maternal age and gestational age at delivery, higher birth weight, African-American
ethnicity, nulliparity, female fetal sex, and a lower rate of chronic inflammation of the
placenta. However, spontaneous labor status (presence versus absence) and other placental
pathologies were not associated with the occurrence of TICCT.
Multiple logistic regression analysis was performed to control for clinical parameters, such
as ethnicity, maternal age, parity, gestational age at delivery, fetal sex, birth weight, and
chronic inflammation of the placenta, that were significantly different according to the
presence or absence of TICCT (Table 1). TICCT was 80% less likely to be detected in the
membranes of Hispanic women than in those of African-American women (OR: 0.23, 95%
CI: 0.18–0.31, p<0.001); similarly, TICCT was 40% less likely to be detected in the
membranes of multiparas compared to nulliparas (OR: 0.60, 95% CI: 0.44–0.81, p=0.001).
Interestingly, TICCT was 70% more prevalent in the membranes of female rather than male
fetuses (OR: 1.64, 95% CI: 1.28–2.11, p<0.001). Detectable TICCT was 40% less likely to
occur in placentas with lesions of chronic inflammation (OR: 0.60, 95% CI: 0.45–0.81,
p=0.001).
The detection of TICCT increased as a function of gestational age. The likelihood of TICCT
increased by 30% with each week of gestation (OR: 1.29, 95% CI: 1.16–1.45, p<0.001).
Maternal age was not significantly associated with TICCT (OR: 0.998, 95% CI: 0.97–1.03,
p=0.903.
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The extent of TICCT was diagnosed as grade 1 in 28.3% (339/1199), grade 2 in 14.3%
(171/1199), and grade 3 in 6.4% (77/1199) in uncomplicated term deliveries among African-
American and Hispanic women. Controlling for potentially confounding factors (ethnicity,
parity, fetal sex, and chronic inflammation of the placenta), high-grade TICCT (grade 2 or 3)
was significantly associated with: 1) African-American ethnicity (OR: 6.76, 95% CI: 4.39–
10.42, p<0.001); 2) gestational age at delivery (OR: 1.47, 95% CI: 1.30–1.66, p<0.001); and
3) a female fetus (OR: 1.74, 95% CI: 1.26–2.41, p=0.001). Alternatively, high-grade TICCT
was significantly less common in multiparous women (OR: 0.45, 95% CI: 0.33–0.63,
p<0.001) and those with chronic inflammation of the placenta (OR: 0.48, 95% CI: 0.32–
0.71, p<0.001), adjusted for potential confounders.
3.3. TICCT in the chorioamniotic membranes of preterm deliveries
Given the magnitude of the association between TICCT and gestational age at delivery and
other clinical variables in term pregnancies, findings from the placentas of patients who
delivered preterm were examined in detail. Demographic characteristics of patients with
preterm deliveries according to the presence or absence of TICCT are summarized in Table
2. Results are presented stratified by gestational age at delivery (Group 1: 35–36 weeks,
Group 2: 32–34 weeks, Group 3: 29–31 weeks, Group 4: 24–28 weeks).
There was a strong linear association between TICCT and gestational age at delivery (range
28–36 weeks; p<0.001, by linear-by-linear association). The detection rate of TICCT was
29.4% (107/364), 19.4% (65/335), 14.0% (22/157), and 4.0% (4/100) at 35–36 weeks, 32–
34 weeks, 29–31 weeks, and 24–28 weeks, respectively. TICCT was significantly more
frequent in African-American than in Hispanic women with preterm deliveries (range 28–36
weeks; p<0.001 by M-H test) (Fig. 5). The presence of TICCT was associated with a higher
birth weight, higher gestational age at delivery, African-American ethnicity, female fetal
sex, and a lower rate of chronic inflammation of the placenta (Table 2, p<0.001 for each).
There were no differences in maternal age, etiology of preterm birth, parity, and other
placental pathologies according to the presence or absence of TICCT.
After adjustment for potential confounders (ethnicity, fetal sex, gestational age at delivery,
birth weight, and chronic inflammation of the placenta) (Table 2), Hispanic women were
60% less likely to have TICCT than African-American women (OR: 0.41, 95% CI: 0.29–
0.58, p<0.001). TICCT was two-fold more likely in women carrying a female fetus than in
those with a male fetus (OR: 2.04, 95% CI: 1.46–2.85, p<0.001). The likelihood of TICCT
increased by 20% with each progressive week of gestational age at delivery (OR: 1.19, 95%
CI: 1.07–1.32, p=0.001). TICCT was significantly less prevalent in the presence of chronic
inflammation of the placenta (OR: 0.58, 95% CI: 0.40–0.84, p=0.003).
The extent of TICCT was diagnosed as grade 1 in 15.6% (149/956), grade 2 in 4.4%
(42/956), and grade 3 in 0.7% (7/956) in the preterm deliveries of African-American and
Hispanic women. Controlling for potential confounders (ethnicity, fetal sex, and chronic
inflammation of the placenta), high-grade TICCT (grade 2 or 3) was significantly more
common in African-American women (OR: 2.68, 95% CI: 1.40–5.11, p=0.003), those with
advancing gestational age (OR: 1.32, 95% CI: 1.14–1.54, p<0.001), and those who delivered
a female fetus (OR: 3.89, 95% CI: 2.00–7.55, p<0.001). High-grade TICCT was less
common in placentas with chronic inflammatory lesions (OR: 0.33, 95% CI: 0.15–0.73,
p=0.006).
4. Discussion
We report a novel histological finding in the chorioamniotic membranes, which we define as
“trophoblast islands of the chorionic connective tissue” (TICCT). The primary findings of
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this study are that: 1) TICCT is significantly more likely to occur with advancing gestational
age at delivery; 2) TICCT was more frequent across gestation in African-American than
Hispanic women included in this study; 3) female fetal sex is associated with the presence of
TICCT; 4) TICCT was significantly less common in the presence of chronic placental
inflammation; and 5) maternal age was not associated with TICCT. To the best of our
knowledge, this is the first demonstration showing that placentas of differing fetal sex have
histological differences.
The placenta displays features of growth and differentiation as shown in the development
and maturation of the chorionic villi across gestation [25]. Other histological findings, such
as calcifications [26] and squamous metaplasia of the amnion [23], have been shown to be
more frequent with advancing gestational age. However, TICCT is unique in that its
presence is more likely to occur with advancing gestational age in both preterm and term
cases. We were able to quantitate the increase in the likelihood of TICCT with each
advancing week of gestation. One interpretation is that TICCT may be a phenomenon
associated with placental aging, senescence, or maturation. We are aware of the proposal
that there is a “placental clock” determining the duration of pregnancy, and that such a clock
would operate through the corticotropin-releasing hormone (CRH) [27–29]. The relationship
between TICCT and the control of parturition requires further study.
An unexpected finding of this study was the difference in the frequency of TICCT between
African-American and Hispanic women. Future studies are required for replication and to
determine whether there is variability in the frequency of TICCT among other ethnic groups.
For example, is it biologically plausible that there could be a difference in the frequency of
TICCT among ethnic groups, due to the variability of the length of gestation among such
groups? Similarly, the frequency of preterm birth varies according to race and ethnicity [30–
36]. Patel et al. reported that after studying a cohort of 122,415 nulliparous women, the
median gestational age at delivery was shorter in African-Americans and Asians (39 weeks)
than in white Europeans (40 weeks). The authors also found an increase in the odds of
preterm delivery in African-Americans and Asians compared to white Europeans, adjusted
for body mass index and social deprivation [30]. Variation in the length of normal gestation
has also been found in animals. Murray et al. demonstrated differences in the length of
gestation in 15 inbred mice strains of as much as two full days, and proposed that the
maternal genome may account for much of this variation [37]. The possible relationship
among TICCT, fetal maturation or age, and parturition requires further study.
The association of increased frequency of TICCT and the placentas of female fetuses was
also unexpected. There is some evidence that fetal sex may influence the outcome of
pregnancy [38–40]. Pregnant women with a male fetus have a higher risk of preterm
delivery [39,41,42], gestational diabetes mellitus [40], macrosomia [40], prolonged
pregnancy [43], and abruptio placentae [44]. On the other hand, those with a female fetus
have a higher rate of hyperemesis gravidarum [45], hypertension-related growth restriction
[46], preeclampsia among preterm births [47], and placenta accreta [48]. The serum
concentrations of free beta human chorionic gonadotropin are higher and those of alpha-
fetoprotein are lower in women with a female fetus than in those with a male fetus [49,50].
Other studies have also shown evidence of sexual dimorphism in the biology of the placenta.
Yeganegi et al. have demonstrated that the key cytokine response of placental trophoblasts
to lipopolysaccharide or endotoxin was greater in male fetuses [51], and that up-regulation
of colony-stimulating factor 3 (CSF3) in trophoblasts by Lactobacillus rhamnosus GR-1 was
detected only in trophoblasts obtained from placentas of female fetuses [52]. Murphy et al.
have shown that placental 11β-hydroxysteroid dehydrogenase activity differs between male
and female fetuses in humans [53]. Furthermore, the mean gestational age at delivery of
male fetuses was significantly higher by one day compared to that of female fetuses in
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humans [43]. The difference in the positive rate of TICCT, therefore, is additional and novel
histological evidence that there is indeed a biological difference between pregnancies with
male and female fetuses.
What is the origin of TICCT? Potential histogenetic explanations for TICCT include: 1)
proliferation/migration/differentiation of chorionic extravillous cytotrophoblasts resting on
the basal lamina into the chorionic connective tissue; or 2) de novo transdifferentiation of
the mesenchymal cells of the chorionic connective tissue into trophoblasts (Fig. 6). The
development of TICCT by the first mechanism would be consistent with trophoblast
heterotopia, while the second mechanism would be more akin to trophoblastic metaplasia.
Cases of TICCT showing direct extension of the chorionic trophoblasts into the connective
tissue layer could be explained by the first mechanism. Those cases with isolated
trophoblasts in the midst of the connective tissue layer could be either a consequence of
direct extension or migration/differentiation of extravillous cytotrophoblasts which have lost
a connection with the chorionic trophoblast layer, or a consequence of transdifferentiation of
the mesenchymal cells of the connective tissue. It was intriguing to find the cells with small
nuclei and little but clearly cytokeratin-positive cytoplasm at the border between the
chorionic connective tissue and the trophoblast layer as shown in Fig. 2.
Typically, the mesenchymal cells of the chorionic connective tissue display either a
myofibroblast or macrophage phenotype, and a myofibroblast can acquire a macrophage
phenotype [7,8]. Chorionic mesenchymal stem cells can undergo osteogenic [54] and
neuronal differentiation [55]; yet the stemness of chorionic mesenchymal cells is uncertain
at this time. Immunofluorescence studies have not demonstrated SSEA-3 and SSEA-4 in
these cells [56]. Therefore, migration and differentiation of extravillous cytotrophoblasts
residing in the basal portion of the chorionic trophoblast layer are more likely to explain
TICCT. The basal layer of extravillous cytotrophoblasts, in contact with the basal lamina of
the connective tissue layer, incorporates 3H-thymidine uptake [57]. Kalabis et al. recently
demonstrated in a mouse esophagus that basal cells of the esophageal epithelium are
endowed with properties of stem cells with BrdU uptake [58], and small cytokeratin-positive
cells at the basal portion of the trophoblast layer might be a functionally similar population
of epidermal stem cells of the skin [59].
We previously proposed that there is a transdifferentiation program between myofibroblasts
and macrophages in the chorionic connective tissue [8]. Questions that remain are: (1) what
is the fate of the trophoblasts in TICCT; and (2) do extravillous cytotrophoblasts of the
chorionic trophoblast layer replenish the reservoir of chorionic mesenchymal cells and
macrophages? Although these questions are beyond the scope of the present study, they are
interesting lines for future investigation. Epithelial-mesenchymal transition of trophoblasts
is considered an important feature of placental development. Perturbation of such a process
has been associated with preeclampsia and fetal growth restriction [60,61]. It is also
noteworthy that macrophages and trophoblasts share several properties such as
phagocytosis, syncytialization, and the capacity for invasion [62].
There are limitations in our study. Data on the frequency of TICCT in Caucasian and Asian
women were unavailable. This information would be valuable to determine the extent of
ethnic and racial variability. By its nature, this observational study cannot address the
questions about the biological signals responsible for the migration of the trophoblast and
the constitution of TICCT – this applies to the presence of this histologic feature, as well as
the association with gestational age, fetal sex, or ethnic group. It is well-known that amniotic
fluid concentrations of biologically active molecules (such as prostaglandins and cytokines/
chemokines) change with the progression of gestation and also with fetal sex [63,64]. The
potential relationship between clinical parameters associated with TICCT and various
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biological signals needs to be studied. Similarly, the lower rate of TICCT in placentas with
chronic inflammatory lesions remains to be explained.
In conclusion, we describe herein a new feature in placental pathology – TICCT. The
mechanisms responsible for the generation of this finding need to be explored in depth;
however, this feature has the potential to enhance our understanding of the biology of cells
comprising the human chorion.
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Figure 1. Histologic and immunophenotypic characteristics of ‘trophoblast islands of the
chorionic connective tissue’ (TICCT)
a, c: Scattered cells with amphophilic cytoplasm in the chorionic connective tissue layer
(arrows) in normal term delivery cases at the gestational ages of 41.9 and 40.0 weeks,
respectively. b, d: Double immunofluorescence staining showing cytokeratin-7 (green;
Alexa Fluor® 488) and HLA-G (red; Alex Fluor® 594) positive extravillous trophoblasts in
the chorionic connective tissue layer (*). The border between the chorionic trophoblast layer
and the connective layer is indicated by arrowheads.
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Figure 2. Histological spectrum of TICCT confirmed by immunostaining against cytokeratin-7
a, b: Isolated trophoblasts in the chorionic connective tissue in a case of normal term
delivery at 37.4 weeks of gestation. Fine cytoplasmic connection is evident in one
trophoblast of TICCT. c, d: A cluster of TICCT, which also features direct extension from
the chorionic trophoblasts (normal term delivery, 38.7 weeks). e, f: A cluster of TICCT,
showing many trophoblasts of variable sizes (normal term delivery, 38.6 weeks). Some
trophoblasts have very little cytokeratin-7-positive cytoplasm. g, h: In this image of TICCT,
small cells with little cytoplasm (arrows) extend from the junction of the chorionic
trophoblast layer and the basal lamina of the connective tissue (normal term delivery, 37.4
weeks).
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Figure 3. Tracing of TICCT cells by serial sectioning
The cytokeratin-7 immunostained images of serial sections were taken from two
representative cases (a–h, i–p). Both are normal term-in-labor cases without specific
placental pathological findings (41.7 weeks and 41.9 weeks, respectively). (a–h) Direct
extension of some TICCT cells from the chorionic trophoblast layer is evident (c). (i–p)
Many TICCT cells are isolated from the chorionic trophoblast layer throughout the serial
section planes.
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Figure 4. Ultrastructural features of trophoblasts in TICCT found in a case of normal term
delivery after labor (41.4 weeks)
(a) Cytokeratin-7 immunopositive TICCT. (b) Semi-thin sections disclosing isolated
trophoblasts of TICCT (arrows). (c) Electron microscopic features of TICCT embedded in
an abundant collagen matrix (inset). The cell has euchromatic nuclei with prominent
nucleoli, a fair number of rough endoplasmic reticula and mitochondria, and abundant
intermediate filaments that show its unique differentiation characteristics. Original
magnification: ×4000 (inset), ×10,000.
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Figure 5. The changes in the positive rate of TICCT across gestation in two study populations
(African-American vs. Hispanic)
There is a robust association between the positive rate and advancing gestational age. The
TICCT positive rate is also significantly higher in African-American women who delivered
at Hutzel Women’s Hospital, Detroit, Michigan, USA, than in Hispanic women who
delivered at Sótero del Río Hospital, Santiago, Chile.
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Figure 6. Schematic illustrations of the potential histogenesis (arrows) of TICCT
a. Extravillous cytotrophoblasts sitting on the basal lamina migrate into the chorionic
connective tissues. These small cytokeratin-positive trophoblasts (*) would be functionally
similar to the stem cells described in other types of epithelium such as skin and esophagus.
b. Transdifferentiation of chorionic mesenchymal cells into the trophoblasts. It is uncertain,
however, whether chorionic mesenchymal cells have stemness to undergo trophoblast
differentiation. CCT: chorionic connective tissue, CTBL: chorionic trophoblast layer.
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Table 1
Clinical characteristics of uncomplicated term deliveries and a TICCT positive rate.
TICCT (−) TICCT (+) p value adjusted p valuea
Cases: number [n (%)] 612 (51.0%) 587 (49.0%)
Ethnicity [n (%)] <0.001 <0.001
  African-American 321 (52.5%) 484 (82.5%)
  Hispanic 291 (47.5%) 103 (17.5%)
Maternal age (years, mean ± s.d.) 25.0 (± 5.7) 23.7 (± 5.5) <0.001 0.903
Parity [n (%)] <0.001 0.001
  Nulliparity 175(28.6%) 240 (40.9%)
  Multiparity 437 (71.4%) 347 (59.1%)
GAD (weeks, mean ± s.d.) 39.1(± 1.3) 39.7(± 1.4) <0.001 <0.001
Fetal sex [n (%)] <0.001 <0.001
  Male 355(58.0%) 278 (47.4%)
  Female 257 (42.0%) 309 (52.6%)
Birth weight (grams, mean ± s.d.) 3263 (± 345) 3339 (± 319) <0.001 <0.001b
Spontaneous labor [n (%)] 0.745
  No 236 (38.6%) 221 (37.6%)
  Yes 376 (61.4%) 366 (62.4%)
ACA [n (%)] 0.095
  No 505 (82.5%) 462 (78.7%)
  Yes 107 (17.5%) 125 (21.3%)
MVU [n (%)] 0.357
  No 586 (95.8%) 568 (96.8%)
  Yes 26 (4.2%) 19 (3.2%)
FVTOD [n (%)] 0.961
  No 573 (93.6%) 550 (93.7%)
  Yes 39 (6.4%) 37 (6.3%)
CPI [n (%)] <0.001 0.001
  No 419 (68.5%) 465 (79.2%)
  Yes 193 (31.5%) 122 (20.8%)
GAD: Gestational age at delivery, ACA: acute chorioamnionitis, MVU: maternal vascular underperfusion, FVTOD: fetal vascular thrombo-
occlusive disease, CPI: chronic placental inflammation.
aAdjustment for ethnicity, maternal age, parity, gestational age at delivery, fetal sex, and chronic placental inflammation was based on a multiple
logistic regression model.
bWithout adjustment for gestational age at delivery.
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Table 2
Clinical characteristics of preterm delivery cases and a TICCT positive rate
TICCT (−) TICCT (+) p value adjusted p valuea
Cases: number [n (%)] 758 (79.3%) 198 (20.7%)
Ethnicity [n (%)] <0.001 <0.001
  African-American 302 (39.8%) 129 (65.2%)
  Hispanic 456 (60.2%) 69 (34.8%)
Maternal age (years, mean ± s.d.) 26.0 (± 7.1) 25.4 (± 6.6) 0.259
Parity [n (%)] 0.356
  Nulliparity 299 (39.4%) 71 (35.9%)
  Multiparity 459 (60.6%) 127 (64.1%)
GAD (weeks, mean ± s.d.) 33.0 (± 3.1) 34.5 (± 2.1) <0.001 0.001
Fetal sex [n (%)] <0.001 <0.001
  Male 453 (59.8%) 81 (40.9%)
  Female 305 (40.2%) 117 (59.1%)
Birth weight (grams, mean ± s.d.) 2026 (± 677) 2271 (± 619) <0.001 <0.001b
Diagnosis [n (%)] 0.879
  Preterm labor 324 (42.7%) 89 (44.9%)
  pPROM 240 (31.7%) 52 (26.3%)
  Preeclampsia 194 (25.6%) 57 (28.8%)
Spontaneous labor [n (%)] 0.058
  No 344 (45.4%) 75 (37.9%)
  Yes 414 (54.6%) 123 (62.1%)
ACA [n (%)] 0.911
  No 633 (83.5%) 166 (83.8%)
  Yes 125 (16.5%) 32 (16.2%)
MVU [n (%)] 0.857
  No 613(80.9%) 159 (80.3%)
  Yes 145(19.1%) 39 (19.7%)
FVTOD [n (%)] 0.109
  No 710 (93.7%) 179 (90.4%)
  Yes 48 (6.3%) 19 (9.6%)
CPI [n (%)] <0.001 0.003
  No 456 (60.2%) 147 (74.2%)
  Yes 302 (39.8%) 51 (25.8%)
GAD: Gestational age at delivery, pPROM: preterm prelabor rupture of membranes, ACA: acute chorioamnionitis, MVU: maternal vascular
underperfusion, FVTOD: fetal vascular thrombo-occlusive disease, CPI: chronic placental inflammation.
aAdjustment for ethnicity, gestational age at delivery, fetal sex, and chronic inflammation of the placenta was based on a multiple logistic
regression model.
bWithout adjustment for gestational age at delivery.
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